BNP Paribas Health Cr Innovtr Cl Cap

Performance History30/04/2024
Growth of 1,000 (EUR)
BNP Paribas Health Cr Innovtr Cl Cap
Fund9.518.81.10.38.8
+/-Cat-1.72.210.91.15.4
+/-Idx--7.21.00.52.5
 
Key Stats
NAV
16/05/2024
 EUR 1700.93
Day Change -0.68%
Morningstar Category™ Sector Equity Healthcare
ISIN LU0823416762
Fund Size (Mil)
16/05/2024
 EUR 1659.48
Share Class Size (Mil)
16/05/2024
 EUR 1191.32
Max Initial Charge 3.00%
Ongoing Charge
29/04/2024
  1.98%
Investment Objective: BNP Paribas Health Cr Innovtr Cl Cap
Increase the value of its assets over the medium term by investing in healthcare innovative companies.
Returns
Trailing Returns (EUR)16/05/2024
YTD10.71
3 Years Annualised9.02
5 Years Annualised11.14
10 Years Annualised9.98
12 Month Yield 0.00
Management
Manager Name
Start Date
Jon Stephenson
02/05/2016
Christian Fay
09/07/2018
Inception Date
17/05/2013
Advertisement
Benchmarks
Fund BenchmarkMorningstar Benchmark
MSCI World/Health Care 10/40 NR EURMorningstar Gbl Health TME NR USD
Target Market
Role In Portfolio
Standalone / CoreNot Specific
ComponentNot Specific
OtherNot Specific
Primary Objective
PreservationNot Specific
GrowthYes
IncomeNot Specific
HedgingNot Specific
OtherNot Specific
Portfolio Profile for  BNP Paribas Health Cr Innovtr Cl Cap31/03/2024
Morningstar Style Box®
Equity Style
Asset Allocation
  % Long% Short% Net Assets
Stocks99.100.0099.10
Bonds0.000.000.00
Cash0.900.000.90
Other0.000.000.00
Top 5 Regions%
United States73.55
United Kingdom8.18
Europe - ex Euro7.65
Eurozone7.49
Japan2.51
Top 5 Sectors%
Healthcare100.00
Top 5 HoldingsSector%
Eli Lilly and CoHealthcareHealthcare8.19
UnitedHealth Group IncHealthcareHealthcare6.95
AstraZeneca PLCHealthcareHealthcare6.27
Sanofi SAHealthcareHealthcare5.15
Boston Scientific CorpHealthcareHealthcare4.78
BNP Paribas Health Cr Innovtr Cl Cap
This fund has performance data calculated prior to the inception date of the fund. This is based upon a simulated/extended track record and is in accordance with Morningstar’s Extended Performance Methodology paper. To find out more about this, click here.
In order to provide consistency across the report data provided by different Asset Managers, the calculated data points presented are generated using Morningstar’s proprietary calculation methodology which is set out in more detail at(https://www.morningstar.com/research/signature)
© Copyright 2024 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Cookie Settings        Disclosures